Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominik Heim

Showing results (21-30 of 120) with videos related to

Pageof 12
Sort By:
European Journal of Haematology|February 3, 2006
Cyclosporine-responsive thrombocytopenia in a patient with chloramphenicol-associated myelodysplastic syndromeCaroline Arber, Andreas Buser, Dominik Heim, et al.
Transplantation and Cellular Therapy|May 15, 2025
Busulfan Once Versus Four Times Daily: Impact on Pharmacokinetics, Organ Toxicities and Survival After Allogeneic Hematopoietic Stem Cell TransplantationClaire Seydoux, Jakob R Passweg, Dominik Heim, et al.
Anticancer Research|February 11, 2015
Angiogenic markers in plasma cell myeloma patients treated with novel agentsMichael Medinger, Jörg Halter, Dominik Heim, et al.
Therapeutische Umschau. Revue Therapeutique|March 12, 2020
[Hematopoietic cell transplantation - essentials on indication, patient referral and long term follow up]Jörg P Halter, Sabine Gerull, Christian Arranto, et al.
International Journal of Laboratory Hematology|November 27, 2019
Peripheral blood schistocytes in the acute phase after allogeneic or autologous stem cell transplantation assessed by digital microscopyMeropi Karakioulaki, Maria Martinez, Michael Medinger, et al.
Cancer Genomics & Proteomics|July 2, 2016
Gene-expression Profiling in Patients with Plasma Cell Myeloma Treated with Novel AgentsMichael Medinger, Jörg Halter, Dominik Heim, et al.
Acta Oncologica (Stockholm, Sweden)|March 24, 2010
Fatal myocardial infarction during nilotinib treatment in a 60-year-old male patientYolanda B Brauchli, Thomas Wais, Alois Gratwohl, et al.
Bone Marrow Transplantation|April 1, 2022
Impact of busulfan pharmacokinetics on outcome in adult patients receiving an allogeneic hematopoietic cell transplantationClaire Seydoux, Raphael Battegay, Joerg Halter, et al.
European Journal of Haematology|March 30, 2007
Oral health risks associated with HLA-types of patients undergoing hematopoietic stem cell transplantationTereza Dobr, Jakob Passweg, Catherine Weber, et al.
Leukemia Research|April 24, 2017
Hypothyroidism following allogeneic hematopoietic stem cell transplantation for acute myeloid leukemiaMichael Medinger, Deborah Zeiter, Dominik Heim, et al.
Pageof 12

Showing results (21-30 of 120) with videos related to

Sort By:
Pageof 12
European Journal of Haematology|February 3, 2006
Cyclosporine-responsive thrombocytopenia in a patient with chloramphenicol-associated myelodysplastic syndromeCaroline Arber, Andreas Buser, Dominik Heim, et al.
Transplantation and Cellular Therapy|May 15, 2025
Busulfan Once Versus Four Times Daily: Impact on Pharmacokinetics, Organ Toxicities and Survival After Allogeneic Hematopoietic Stem Cell TransplantationClaire Seydoux, Jakob R Passweg, Dominik Heim, et al.
Anticancer Research|February 11, 2015
Angiogenic markers in plasma cell myeloma patients treated with novel agentsMichael Medinger, Jörg Halter, Dominik Heim, et al.
Therapeutische Umschau. Revue Therapeutique|March 12, 2020
[Hematopoietic cell transplantation - essentials on indication, patient referral and long term follow up]Jörg P Halter, Sabine Gerull, Christian Arranto, et al.
International Journal of Laboratory Hematology|November 27, 2019
Peripheral blood schistocytes in the acute phase after allogeneic or autologous stem cell transplantation assessed by digital microscopyMeropi Karakioulaki, Maria Martinez, Michael Medinger, et al.
Cancer Genomics & Proteomics|July 2, 2016
Gene-expression Profiling in Patients with Plasma Cell Myeloma Treated with Novel AgentsMichael Medinger, Jörg Halter, Dominik Heim, et al.
Acta Oncologica (Stockholm, Sweden)|March 24, 2010
Fatal myocardial infarction during nilotinib treatment in a 60-year-old male patientYolanda B Brauchli, Thomas Wais, Alois Gratwohl, et al.
Bone Marrow Transplantation|April 1, 2022
Impact of busulfan pharmacokinetics on outcome in adult patients receiving an allogeneic hematopoietic cell transplantationClaire Seydoux, Raphael Battegay, Joerg Halter, et al.
European Journal of Haematology|March 30, 2007
Oral health risks associated with HLA-types of patients undergoing hematopoietic stem cell transplantationTereza Dobr, Jakob Passweg, Catherine Weber, et al.
Leukemia Research|April 24, 2017
Hypothyroidism following allogeneic hematopoietic stem cell transplantation for acute myeloid leukemiaMichael Medinger, Deborah Zeiter, Dominik Heim, et al.
Pageof 12